The global microbiome skincare products market size was estimated at around USD 381.54 million in 2022 and it is projected to hit around USD 1,075.57 million by 2032, growing at a CAGR of 10.92% from 2023 to 2032.
Key Pointers
Report Scope of the Microbiome Skincare Products Market
Report Coverage | Details |
Market Size in 2022 | USD 381.54 million |
Revenue Forecast by 2032 | USD 1,075.57 million |
Growth rate from 2023 to 2032 | CAGR of 10.92% |
Base Year | 2022 |
Forecast Period | 2023 to 2032 |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Regions Covered | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
Companies Covered | Vichy Laboratoires; L'Oréal Paris; Amyris; OUTIN FUTURES INC.; Missha; Eminence Organic Skin Care; La Roche-Posay; Aveeno (J&JCI); Elizabeth Arden; Glowbiotics LLC; GALLINÉE; Murad LLC; BioGaia; Amorepacific |
Key factors driving the market growth are the increasing incidence of skin-related diseases, such as acne. According to the American Academy of Dermatology Association, about 50 million people in the U.S. suffer from acne, which is one of the leading factors for disrupting the human skincare microbiome. Microbiome skincare products are an important and effective tool in maintaining healthy skin. Thus, the growing prevalence of skin diseases will propel product demand over the forecast period.
The skincare market has undergone significant changes in recent years, with a growing focus on microbiomes and a trend toward minimalism. Consumers are becoming more engaged and actively seeking out the latest trends, products, and ingredients, creating an opportunity and a responsibility for brands and beauty professionals to educate them appropriately.The focus of skincare has shifted from simply providing a pleasant skin sensation to improving overall skin health. This change is reflected in the growing popularity of microbiome-friendly products that support the skin’s natural defense system and help restore the microbiome to its natural state.
In addition, the trend towards minimalism also reflects a desire for simpler, more natural products that are free of harmful chemicals and unnecessary additives.In the early days of the pandemic, the sale of microbiome skincare products declined due to the lockdown imposed by governments across the globe to curb the spread of the infection. However, companies are witnessing high demand for skin care products post-pandemic due to the opening of the economy and increasing beauty consciousness among the young population. For instance, on Google, searches with the ‘microbiome skincare’ keywords increased by 5,000% in 2021. This shows the increasing interest of the population in such products.
Product Insights
The creams segment dominated the industry in 2022 and accounted for the largest share of 36.82% of the overall revenue. The increasing approval and launch of new creams to maintain and prevent disruption of the healthy microbiome on the skin is a key factor driving the product demand. As per OPS Publishes, creams are highly adopted due to their lightweight formulation and hydration effects and, therefore, are the largest contributor to the segmental revenue.The serum segment is anticipated to witness lucrative growth during the forecast period.
This growth can be attributed to extended serum approval to prevent skin microbiome disruption. Several serums available in the market are formulated to support a healthy skin microbiome, including probiotic & prebiotic serums, Niacinamide serums, and Vitamin C serums. For instance, iORA Prebiotic Radiant, Vichy Minéral 89 Probiotic Fractions Repairing, and Murad Prebiotic 3-in-1 Multimist have widely used serums available in the market. The introduction of highly effective and long-lasting effects-providing serums is projected to drive segment growth.
Distribution Channel Insights
The hypermarket/supermarket distribution channel segment dominated the market in 2022 and accounted for the largest share of 39.04% of the overall revenue. This dominance can be attributed to the fact that purchasing skincare microbiome products in the supermarket can be a convenient and accessible way to incorporate these products into a skincare routine. According to the Food Industry Association, there were around 38,307 supermarkets in the U.S., in 2018. Supermarkets carry well-known brands that many people trust, and these brands often have a wide range of skincare products that cater to different skin types and concerns. Thus, the emergence of new supermarkets offering skincare microbiome products is expected to fuel segment growth.
The e-commerce segment is also anticipated to have significant growth during the forecast period owing to increased buyer preference to purchase beauty products through online platforms post-pandemic. The pandemic shut down the entire world. The difference between online and offline stores was evident as soon as the economy opened. According to the National Library of Medicine, the sale of beauty products increased by 133% for retailers with online supply facilities in January 2021. Currently, Shopify Plus, Banuba, Argano, and nopCommerce are some of the major e-commerce platforms offering various beauty products, including skincare microbiome.
Regional Insights
North America dominated the industry in 2022 and accounted for the largest share of 34.14% of the overall revenue. This can be attributed to supportive regulatory policies regarding the clearance and approval of new products for sale in the market. Codex Beauty announced in May 2020 that its skincare line, Bia, received Microbiome-friendly certification for all six face products from the My Microbiome Standard 18.10. This certification evaluates skincare products based on their impact on the skin microbiome. It ensures that the products are formulated with ingredients that are beneficial to the skin microbiome and do not contain any harmful substances. This achievement demonstrates Codex Beauty’s commitment to producing safe and effective clean beauty skincare products, driving market growth in the North America region.
Asia Pacific is anticipated to register the fastest CAGR during the forecast period due to the growing aging population, high prevalence of skin diseases, and a rise in per capita disposable incomes. Age, gender, and ethnicity are the most important factors specific to individual hosts and affect the skin microbiome. As per an article published by Secret Life of Skin, sensitive skin is a major concern among Asian consumers, with 60% of Korean women said to have sensitive skin. To tackle this, in 2018, Amorepacific group launched a ‘Probiotic Skin Barrier’ line for the brand Illiyoon, which is formulated with an exclusive probiotic – fermented lactobacillus derived from gat kimchi. The introduction of such novel products is expected to boost market growth.
Microbiome Skincare Products Market Segmentations:
By Product
By Distribution Channel
By Regional
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Microbiome Skincare Products Market
5.1. COVID-19 Landscape: Microbiome Skincare Products Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Microbiome Skincare Products Market, By Product
8.1. Microbiome Skincare Products Market, by Product, 2023-2032
8.1.1. Serums
8.1.1.1. Market Revenue and Forecast (2020-2032)
8.1.2. Creams
8.1.2.1. Market Revenue and Forecast (2020-2032)
8.1.3. Masks
8.1.3.1. Market Revenue and Forecast (2020-2032)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 9. Global Microbiome Skincare Products Market, By Distribution Channel
9.1. Microbiome Skincare Products Market, by Distribution Channel, 2023-2032
9.1.1. Hypermarket/Supermarket
9.1.1.1. Market Revenue and Forecast (2020-2032)
9.1.2. Pharmacy & Drug Stores
9.1.2.1. Market Revenue and Forecast (2020-2032)
9.1.3. E-commerce
9.1.3.1. Market Revenue and Forecast (2020-2032)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2020-2032)
Chapter 10. Global Microbiome Skincare Products Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2020-2032)
10.1.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.1.3.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.1.4.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.3.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.4.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.5.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product (2020-2032)
10.2.6.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.3.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.4.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.5.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product (2020-2032)
10.3.6.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.3.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.4.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.5.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product (2020-2032)
10.4.6.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2020-2032)
10.5.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product (2020-2032)
10.5.3.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product (2020-2032)
10.5.4.2. Market Revenue and Forecast, by Distribution Channel (2020-2032)
Chapter 11. Company Profiles
11.1. Vichy Laboratoires
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. L'Oréal Paris
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Amyris
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. OUTIN FUTURES INC.
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Missha
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Eminence Organic Skin Care
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. La Roche-Posay
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Aveeno (J&JCI)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Elizabeth Arden
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Glowbiotics LLC
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms